Saroglitazar Magnesium 4 mg for Nonalcoholic Fatty Liver Disease (NAFLD) in People Living With HIV in the US

NCT05211284 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor Decision

Conditions

Nonalcoholic Fatty Liver Disease

Interventions

DRUG: Saroglitazar Magnesium 4 mg
DRUG: Placebo

Sponsor

Zydus Therapeutics Inc.